Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.
School of Health Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.
Int J Lab Hematol. 2021 Dec;43(6):1451-1457. doi: 10.1111/ijlh.13628. Epub 2021 Jun 14.
Calreticulin (CALR) mutations in myeloproliferative neoplasms (MPN) have been reported to be key markers in the molecular diagnosis, particularly in patients lacking JAK2 V617F mutation. In most current reports, CALR mutations were analysed by either allele-specific PCR (AS-PCR), or the more expensive quantitative real-time PCR, pyrosequencing and next-generation sequencing. Hence, we report the use of an alternative method, the conformation sensitive gel electrophoresis (CSGE) for the detection of CALR mutations in BCR-ABL1-negative MPN patients.
Forty BCR-ABL1-negative MPN patients' DNA: 19 polycythemia vera (PV), 7 essential thrombocytosis (ET) and 14 primary myelofibrosis (PMF), were screened for CALR mutations by CSGE. PCR primers were designed to amplify sequences spanning between exons 8 and 9 to target the mutation hotspots in CALR. Amplicons displaying abnormal CSGE profiles by electrophoresis were directly sequenced, and results were analysed by BioEdit Sequence Alignment Editor v7.2.6. CSGE results were compared with AS-PCR and confirmed by Sanger sequencing.
CSGE identified 4 types of mutations; 2 PMF patients with either CALR type 1 (c.1099_1150del52) or type 2 (c.1155_1156insTTGTC), 1 ET patient with nucleotide deletion (c.1121delA) and insertion (c.1190insA) and 1 PV patient with p.K368del (c.1102_1104delAAG) and insertion (c.1135insA) inframe mutations. Three patients have an altered KDEL motif at the C-terminal of CALR protein. In comparison, AS-PCR only able to detect two PMF patients with mutations, either type 1 and type 2.
CSGE is inexpensive, sensitive and reliable alternative method for the detection of CALR mutations in BCR-ABL1-negative MPN patients.
在骨髓增殖性肿瘤(MPN)中已经报道钙网织蛋白(CALR)突变是分子诊断的关键标志物,特别是在缺乏 JAK2 V617F 突变的患者中。在大多数当前的报告中,CALR 突变通过等位基因特异性 PCR(AS-PCR)或更昂贵的定量实时 PCR、焦磷酸测序和下一代测序进行分析。因此,我们报告了一种替代方法,即构象敏感凝胶电泳(CSGE),用于检测 BCR-ABL1 阴性 MPN 患者的 CALR 突变。
40 例 BCR-ABL1 阴性 MPN 患者的 DNA:19 例真性红细胞增多症(PV)、7 例特发性血小板增多症(ET)和 14 例原发性骨髓纤维化(PMF),通过 CSGE 筛选 CALR 突变。设计 PCR 引物以扩增跨越外显子 8 和 9 的序列,以靶向 CALR 的突变热点。通过电泳显示异常 CSGE 图谱的扩增子直接测序,并通过 BioEdit Sequence Alignment Editor v7.2.6 分析结果。CSGE 结果与 AS-PCR 进行比较,并通过 Sanger 测序确认。
CSGE 鉴定出 4 种突变类型;2 例 PMF 患者分别具有 CALR 1 型(c.1099_1150del52)或 2 型(c.1155_1156insTTGTC),1 例 ET 患者具有核苷酸缺失(c.1121delA)和插入(c.1190insA),1 例 PV 患者具有 p.K368del(c.1102_1104delAAG)和插入(c.1135insA)框内突变。3 例患者的 CALR 蛋白 C 末端的 KDEL 基序发生改变。相比之下,AS-PCR 只能检测到 2 例 PMF 患者的突变,分别为 1 型和 2 型。
CSGE 是一种经济、敏感和可靠的替代方法,用于检测 BCR-ABL1 阴性 MPN 患者的 CALR 突变。